112 related articles for article (PubMed ID: 37199515)
1. A visfatin gene promoter polymorphism (rs1319501) is associated with susceptibility to nonalcoholic fatty liver disease.
Mahmoudi T; Ghorbani D; Rezamand G; Dehestan N; Jeddi G; Asadi A; Nobakht H; Dabiri R; Farahani H; Tabaeian SP; Zali MR
Per Med; 2023 Mar; 20(2):157-165. PubMed ID: 37199515
[No Abstract] [Full Text] [Related]
2. Association of rs5742612 Polymorphism in the Promoter Region of IGF1 Gene with Nonalcoholic Fatty Liver Disease: A Case-Control Study.
Nobakht H; Mahmoudi T; Rezamand G; Tabaeian SP; Jeddi G; Asadi A; Farahani H; Dabiri R; Mansour-Ghanaei F; Kaboli SA; Derakhshan F; Zali MR
Lab Med; 2022 Sep; 53(5):504-508. PubMed ID: 35713614
[TBL] [Abstract][Full Text] [Related]
3. Effects of NAMPT polymorphisms and haplotypes on circulating visfatin/NAMPT levels in hypertensive disorders of pregnancy.
Luizon MR; Belo VA; Palei AC; Amaral LM; Lacchini R; Sandrim VC; Duarte G; Cavalli RC; Tanus-Santos JE
Hypertens Res; 2015 May; 38(5):361-6. PubMed ID: 25716650
[TBL] [Abstract][Full Text] [Related]
4. Intracellular nicotinamide phosphoribosyltransferase protects against hepatocyte apoptosis and is down-regulated in nonalcoholic fatty liver disease.
Dahl TB; Haukeland JW; Yndestad A; Ranheim T; Gladhaug IP; Damås JK; Haaland T; Løberg EM; Arntsen B; Birkeland K; Bjøro K; Ulven SM; Konopski Z; Nebb HI; Aukrust P; Halvorsen B
J Clin Endocrinol Metab; 2010 Jun; 95(6):3039-47. PubMed ID: 20392873
[TBL] [Abstract][Full Text] [Related]
5. Insulin-like growth factor binding protein 3 promoter variant (rs2854744) is associated with nonalcoholic fatty liver disease.
Mahmoudi T; Nouri S; Zarei F; Najafabadi ZN; Sanei M; Sayedsalehi S; Rezamand G; Asadi A; Dabiri R; Nobakht H; Farahani H; Tabaeian SP; Zali MR
Arch Endocrinol Metab; 2023 Nov; 68():e230017. PubMed ID: 37948568
[TBL] [Abstract][Full Text] [Related]
6. The effects of NAMPT haplotypes and metabolic risk factors on circulating visfatin/NAMPT levels in childhood obesity.
Belo VA; Luizon MR; Lacchini R; Miranda JA; Lanna CM; Souza-Costa DC; Tanus-Santos JE
Int J Obes (Lond); 2015 Jan; 39(1):130-5. PubMed ID: 24100423
[TBL] [Abstract][Full Text] [Related]
7. Association of polymorphisms of adiponectin gene promoter-11377C/G, glutathione peroxidase-1 gene C594T, and cigarette smoking in nonalcoholic fatty liver disease.
Zhang CX; Guo LK; Qin YM; Li GY
J Chin Med Assoc; 2016 Apr; 79(4):195-204. PubMed ID: 26897098
[TBL] [Abstract][Full Text] [Related]
8. [Study on the interaction between matrix metalloproteinases gene polymorphism and central obesity in nonalcoholic fatty liver disease].
Wu P; Shu Y; Li M; Luo H; Zhang G; Tan S
Zhonghua Liu Xing Bing Xue Za Zhi; 2015 Dec; 36(12):1415-8. PubMed ID: 26850403
[TBL] [Abstract][Full Text] [Related]
9.
Pereira DA; Sandrim VC; Palei AC; Amaral LM; Belo VA; Lacchini R; Cavalli RC; Tanus-Santos JE; Luizon MR
Pharmacogenomics; 2021 Jun; 22(8):451-464. PubMed ID: 33944612
[No Abstract] [Full Text] [Related]
10. Insulin receptor substrate 2 gene Gly1057Asp polymorphism is a risk factor for nonalcoholic fatty liver disease.
Nouri S; Mahmoudi T; Hojjati F; Najafabadi ZN; Shafiee R; Sayedsalehi S; Dehghanitafti A; Ardalani A; Kohansal K; Rezamand G; Asadi A; Nobakht H; Dabiri R; Farahani H; Tabaeian SP; Zali MR
Lab Med; 2024 Mar; 55(2):215-219. PubMed ID: 37481466
[TBL] [Abstract][Full Text] [Related]
11. Gene-gene interactions in the NAMPT pathway, plasma visfatin/NAMPT levels, and antihypertensive therapy responsiveness in hypertensive disorders of pregnancy.
Luizon MR; Palei ACT; Belo VA; Amaral LM; Lacchini R; Duarte G; Cavalli RC; Sandrim VC; Tanus-Santos JE
Pharmacogenomics J; 2017 Oct; 17(5):427-434. PubMed ID: 27168100
[TBL] [Abstract][Full Text] [Related]
12. The Leu72Met (rs696217 G>T) Polymorphism of the Ghrelin Gene Might Be a Protective Factor for Nonalcoholic Fatty Liver Disease.
Tabaeian SP; Mahmoudi T; Sabzikarian M; Rezamand G; Dabiri R; Nobakht H; Asadi A; Farahani H; Mansour-Ghanaei F; Zali MR
J Gastrointestin Liver Dis; 2021 Jun; 30(2):233-239. PubMed ID: 34174062
[TBL] [Abstract][Full Text] [Related]
13. Apolipoprotein C3 (-455T>C) polymorphism confers susceptibility to nonalcoholic fatty liver disease in the Southern Han Chinese population.
Li MR; Zhang SH; Chao K; Liao XH; Yao JY; Chen MH; Zhong BH
World J Gastroenterol; 2014 Oct; 20(38):14010-7. PubMed ID: 25320541
[TBL] [Abstract][Full Text] [Related]
14. INSULIN AND INSULIN RECEPTOR GENE POLYMORPHISMS AND SUSCEPTIBILITY TO NONALCOHOLIC FATTY LIVER DISEASE.
Nobakht H; Mahmoudi T; Sabzikarian M; Tabaeian SP; Rezamand G; Asadi A; Farahani H; Dabiri R; Mansour-Ghanaei F; Maleki I; Zali MR
Arq Gastroenterol; 2020; 57(2):203-208. PubMed ID: 33206859
[TBL] [Abstract][Full Text] [Related]
15. Genetic variant in visfatin gene promoter is associated with decreased risk of coronary artery disease in a Chinese population.
Yan JJ; Tang NP; Tang JJ; Jia EZ; Wang MW; Wang QM; Zhu J; Yang ZJ; Wang LS; Huang J
Clin Chim Acta; 2010 Jan; 411(1-2):26-30. PubMed ID: 19804767
[TBL] [Abstract][Full Text] [Related]
16. [Interaction of polymorphisms of monocyte chemoattractant protein-1 receptor CCR2 gene 190A/G, nicotinamide adenine dinucleotide phosphate oxidase subunit p22phox gene C242T and cigarette smoking increases the risk of nonalcoholic fatty liver disease].
Zhang C; Guo L
Wei Sheng Yan Jiu; 2015 Sep; 44(5):730-7. PubMed ID: 26591766
[TBL] [Abstract][Full Text] [Related]
17. [AGT rs5051 gene polymorphism increases the risk of coronary heart disease in patients with non-alcoholic fatty liver disease in the Han Chinese population].
Dong MZ; Lin ZH; Liu SS; Xin YN; Xuan SY
Zhonghua Gan Zang Bing Za Zhi; 2021 Nov; 29(11):1095-1100. PubMed ID: 34933429
[No Abstract] [Full Text] [Related]
18. Association of Circulating Adipsin, Visfatin, and Adiponectin with Nonalcoholic Fatty Liver Disease in Adults: A Case-Control Study.
Qiu Y; Wang SF; Yu C; Chen Q; Jiang R; Pei L; Huang YL; Pang NZ; Zhang Z; Ling W; Yang L
Ann Nutr Metab; 2019; 74(1):44-52. PubMed ID: 30541001
[TBL] [Abstract][Full Text] [Related]
19. [Association of single nucleotide polymorphism of SIRT1 and APOC3 with nonalcoholic fatty liver disease].
Song X; Song C; Fan L; Ma Q; Mao J; Xu W; Li X
Wei Sheng Yan Jiu; 2017 Jul; 46(4):527-532. PubMed ID: 29903170
[TBL] [Abstract][Full Text] [Related]
20. Association of plasma visfatin with hepatic and systemic inflammation in nonalcoholic fatty liver disease.
Genc H; Dogru T; Kara M; Tapan S; Ercin CN; Acikel C; Karslioglu Y; Bagci S
Ann Hepatol; 2013; 12(4):548-55. PubMed ID: 23813132
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
